Medical Equipment Components Segment, by Product Type to Account Largest Share in Medical Injection Molding Market during 2024-2031

According to our new research study on "Medical Injection Molding Market Forecast to 2031 - Global Analysis - by Material, Type, End User, Product Type, System, and Geography," the market was valued at US$ 7,525.22 million in 2024 and is projected to reach US$ 10,801.10 million by 2031; it is expected to register a CAGR of 5.3% from 2024 to 2031. The medical injection molding market growth is attributed to the increasing demand for medical devices and equipment, and advancements in molding technologies.

Advancements such as all-electric injection molding and micro-molding have made a big difference in the production of medical devices, thereby fueling the overall medical injection molding market progress. All-electric machines are especially valuable for their energy efficiency and precise control, which are essential when manufacturing high-quality medical components. These machines can operate compatibly in cleanroom environments, ensuring contamination-free output that meets strict hygiene standards. Micro-molding, on the other hand, allows for the creation of incredibly small and precise parts, which is crucial for producing miniature medical devices such as implants and diagnostic tools. Together, these innovations are improving manufacturing processes, reducing waste, and making it easier to maintain the high standards required for medical devices.

Several companies, including MTD Micro Molding, Makuta Technics Inc., Accumold, Sungplastic, and WestFall Technik, have made significant advancements in injection molding technologies, particularly in all-electric machines and micro-molding, to enhance the precision, efficiency, and cleanliness of medical device manufacturing process. In 2021, MTD Micro Molding celebrated the grand opening of its expanded medical micro injection molding facility. This expansion was designed to accommodate the burgeoning demand for ultra-precision molded components in the medical device industry. In April 2021, Tederic Machinery Co. launched the NEO series of electric, hybrid injection molding machines. These machines feature a new generation of servo pumps, enabling energy savings of up to 80% compared to traditional hydraulic machines. Additionally, in September 2020, ENGEL introduced e-speed injection molding machines, hybrid machines (2,800 kN) used in the production of thin-walled containers, buckets, lids, etc.

Various governments provide subsidies for healthcare equipment and funding for research into medical devices as part of efforts to support healthcare expansion. The US government, for instance, has long invested significantly in healthcare infrastructure, including funding for medical device research and development. These investments have driven innovation, increasing demand for advanced medical devices and fostering improvements in manufacturing technologies such as precision molding. In August 2023, DuPont, a US-based company providing technology-based materials and solutions, acquired Spectrum Plastics Group for USD 1.75 billion. This acquisition strengthens DuPont's global presence and medical device portfolio while significantly enhancing its medical injection molding capabilities.

The adoption of micro-molding technologies has enabled the creation of highly precise and miniature parts, which are vital for the development of modern medical devices. At the same time, there is a growing trend toward using bio-based materials to meet the increasing demand for environmentally sustainable and safe medical products. Companies such as Accumold, MTD Micro Molding, and Makuta Technics highly focus on bolstering their micro-molding capabilities, enhancing their production processes to cater to the need for small, complex medical components. These companies continue to innovate and optimize their manufacturing methods to deliver parts with exceptional precision. Similarly, firms such as DuPont and Cavestro are at the forefront of advancements in bio-based materials, which is evident through the launch of bio-based Tyvek and bio-based polycarbonate, respectively. Both companies are committed to offering more sustainable solutions, ensuring that the materials used in medical devices are both high-performing and environmentally friendly.

Based on material, the medical injection molding market is segmented into Polyvinyl Chloride (PVC), Poly(methyl methacrylate) (PMMA), Polyether Ether Ketone (PEEK), metals, others. The others segment held a larger medical injection molding market share in 2024, and the segment is expected to register a higher CAGR during 2024-2031. Other materials used in medical injection molding include elastomers, bioresorbable polymers, and ceramics. Thermoplastic elastomers (TPE) are frequently used in producing flexible medical components such as seals, gaskets, and soft-touch surfaces for medical devices, as they offer both durability and biocompatibility. Bioresorbable polymers such as polylactic acid (PLA) and polycaprolactone (PCL) are popularly being used in the production of implants and drug delivery systems due to their natural degradability within the body, eliminating the need for surgical removal. Bioresorbable polymers gather significant interest in these specialized materials with the surging demand for more advanced, patient-specific medical devices. Additionally, continuous innovations in materials science open new possibilities in the medical injection molding market. For instance, the use of ceramics is increasing in the manufacturing of joint replacement materials, where hardness, wear resistance, and specific performance characteristics are crucial, which exemplifies the growing application of non-traditional materials.

Based on type, the market is segmented into plastic injection molding, overmolding, liquid silicone molding, and others. The plastic injection molding segment held the largest medical injection molding market share in 2024, and the same segment is estimated to register the higher CAGR during 2024-2031. Plastic (regular) injection molding is mostly used due to its cost-effectiveness, versatility, and ability to meet the high demand for disposable medical devices. Regular plastics such as polyethylene (PE), polypropylene (PP), and polystyrene (PS) are widely used in the production of essential medical components, including syringes, IV bags, catheters, and diagnostic tools. These materials are valued for their biocompatibility, ease of sterilization, and ability to be molded into complex shapes with high precision. Additionally, plastics such as PP are commonly used in medical containers, while PE is often selected for making flexible tubing and bottles for pharmaceutical applications. The increasing use of single-use medical devices, driven by both cost considerations and infection control measures, further strengthens the demand for regular plastic injection molding. The increasing focus of healthcare providers on affordability, quality, and precision makes regular plastics a crucial material choice in the production of a wide range of medical products.

Based on end user, the market is segmented into medical devices companies, pharmaceutical drug packaging, surgical instruments companies, and others. The medical devices companies segment held the largest medical injection molding market share in 2024, and the same segment is estimated to register the highest CAGR during 2024-2031. Medical device companies seek high-performance, precise, and cost-effective components. The quality and performance of diagnostic equipment, infusion pumps, blood glucose meters, and personal protective equipment (PPE) often depend on the performance of injection-molded plastic components. These components must meet stringent safety and quality standards to ensure patient safety and device functionality. Injection molding serves as an efficient method for manufacturing complex, high-precision parts at scale, with consistent quality.

Philips Healthcare, Siemens Healthineers, and Baxter International, among others, leverage injection molding for the production of critical device components, including housing, connectors, and enclosures. For instance, Baxter manufactures infusion pumps and dialysis machines with molded parts that contribute significantly to the end products' reliability and durability. Further, the current inclination toward wearable medical devices, home healthcare equipment, and diagnostic tools fuels the demand for lightweight and affordable injection-molded parts complying with various regulatory specifications. Therefore, the progress in areas of home healthcare and point-of-care diagnostics drives the demand for high-quality, molded components within the medical device manufacturing industry.

Aberdeen Technologies, Inc; Husky Technologies; The Rodon Group; UPG International; Proto Labs; C&J Industries; Ensinger; Sanner GmbH; Feronyl; Biomerics LLC; HTI Plastics; Tessy Plastics; and Kaysun Corporation are among the leading companies operating in the global medical injection molding market.

Companies operating in the medical injection molding market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the medical injection molding market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall medical injection molding market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

Contact Us
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com